The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study.
 
Yong Zhang
No Relationships to Disclose
 
Shaomin Che
No Relationships to Disclose
 
Nanzheng Chen
No Relationships to Disclose
 
Xinju Li
No Relationships to Disclose
 
Junke Fu
No Relationships to Disclose
 
Chenao Yu
No Relationships to Disclose
 
Tianren Wang
No Relationships to Disclose
 
Runjia Liang
No Relationships to Disclose
 
Haozhen Xu
No Relationships to Disclose
 
Qifei Wu
No Relationships to Disclose
 
Zhuoqi Jia
No Relationships to Disclose
 
Cailin Zhu
No Relationships to Disclose
 
Tuotuo Gong
No Relationships to Disclose
 
Haijun Li
No Relationships to Disclose
 
Boxiang Zhang
No Relationships to Disclose
 
Yunyun Hu
No Relationships to Disclose
 
Yaqi Liu
No Relationships to Disclose